Global Gross Domestic Product, Tourism/Travel, & Medical Markets to 2025 with COVID-19 Impact - Limited Spread & Early Vaccine /Contained Spread & Midterm Vaccine / Uncontained Spread & Late Vaccine

News provided by

Dec 10, 2020, 12:00 ET

DUBLIN, Dec. 10, 2020 /PRNewswire/ -- The "COVID-19: Economic Impact and Market Forecasts for Gross Domestic Product, Tourism/travel, and Medical by Country using 3 scenarios - 2020-2025" report has been added to ResearchAndMarkets.com's offering.

COVID-19 is turning into a pandemic. Prepare your organization for the changes beginning to take place. Develop an understanding of the risks and probabilities and learn how your industry and your nation will be affected.

This report uses an econometric model to forecast the effect that the COVID-19 pandemic will have on the economies of different countries in the world over the next 5 years. It also forecasts the effect on Tourism and affected Medical Markets during this timeframe.

The modelling is based on 3 scenarios of infection prevalence forecast separately for each major country in the world using economic forecasting combined with the World Health Organization Global Health Security Index System and country specific factor

This in-depth report puts you in control of the numbers you need to prepare. Some countries and some industries will be more affected than others, while some may not be affected at all. This research makes you an expert in your organization. Get the research team working for you by ordering this comprehensive report.

Report Features:

The report features a Situation Analysis which summarizes this serious situation and suggests what is likely to happen. This is intended for CEOs and Strategic Planners.
The report has a Guide for Executives which is intended for operational executives like General Managers, Vice Presidents, and Directors. It has guidelines for policy etc.
The report has a Guide for Investment Managers and Management Consultants which looks at the picture from a finance viewpoint suggesting how industries and stocks might be affected.

Key Topics Covered:

i. COVID-19. Strategic Situation Analysis
ii. COVID-19. Guidance for Executives
iii. COVID-19. Guidance for Management Consultants and Investment Advisors

1. Introduction and Market Definition
1.1 What are Pandemics?
1.2 The Role of Zoonosis
1.3 Market Definition
1.3.1 Revenue Market Size
1.3.2 Gross Domestic Product
1.3.3 Tourism-Hotels
1.3.4 Tourism-Ground
1.3.5 Tourism-Air
1.3.6 Tourism-Cruise
1.3.7 Tourism-Other
1.3.8 Medical -Therapeutic
1.3.9 Medical -Diagnostic
1.3.10 Medical -PPE
1.4 Methodology
1.4.1 Authors
1.4.2 Sources
1.5 Historical Perspective on Pandemics
1.5.1 Hiv/Aids Pandemic 2005-2012
1.5.2 Flu Pandemic 1968
1.5.3 Asian Flu 1956-1958
1.5.4 Spanish Flu 1918
1.5.5 Sixth Cholera Pandemic 1910-1911
1.5.6 Flu Pandemic 1889-1890
1.5.7 The Black Death 1346-1353

2. The Pandemic Overview
2.1 What is a Virus?
2.1.1 Is a Virus Alive?
2.1.2 Viral Structure
2.1.3 The Viral Genome
2.1.4 Viral Mutation
2.2 The Coronavirus
2.2.1 Severe acute respiratory syndrome (SARS)
2.2.2 Middle East respiratory syndrome (MERS)
2.2.3 Coronavirus disease 2019 (COVID-19)
2.2.3.1 Signs and symptoms
2.2.3.2 Cause
2.2.3.3 Diagnosis
2.2.3.4 Prevention
2.2.3.5 Management
2.2.3.6 Prognosis
2.2.3.7 Epidemiology
2.2.3.10 Misinformation about the outbreak
2.3 Pandemic Diagnostics
2.3.1 Risk Management-Spark and Spread
2.3.2 Dx Technology-Genomic and WGS Role
2.3.3 Dx Technology- Immunoassay
2.3.4 Dx Technology-Other
2.3.5 Time to Market and Preparedness Issues
2.4 Therapeutics
2.4.1 Vaccine
2.4.2 Dual Role of Vaccines
2.4.2 Antiviral

3. COVID-19 Scenarios
3.1 Scenarios Overview
3.2 Scenario 1. Limited Spread & Early Vaccine
3.3 Scenario 2. Contained Spread & Midterm Vaccine
3.4 Scenario 3. Uncontained Spread & Late Vaccine

4. Recent Developments
4.1 Recent Developments- Importance and How to Use This Section
4.1.1 Importance of These Developments
4.1.2 How to Use This Section

Generex Signs Contract to Develop a COVID-19 Vaccine
Applied DNA, Takis Biotech Partner To Design COVID-19 Vaccines
Codagenix Developing a Coronavirus Vaccine
Breakthrough From MIGAL Research Institute in Development of COVID-19 Vaccine
Novavax Advances Development of Novel COVID-19 Vaccine
COVID-19 Causes Air Travel to Fall for first time in 11 Years
Steep Drop In Chinese Air Travel Demand
New Tech Could Make Coronavirus Vaccine in Record Time
Vaxart Announces Initiation of Coronavirus Vaccine Program
Coronavirus Detection Test Development by Co-Diagnostics
GeoVax, BravoVax to develop vaccine for coronavirus
Diagnosing coronavirus in the lab
Veredus Lab develops test for coronavirus detection
U.S. Pork Producers fear Pandemic
First New HIV Strain in19 Years Identified
Flu-Like Epidemic Could Kill 80 Mn Globally
Nipah Virus a Global Threat
New DRC Ebola cases confirmed as FDA OKs rapid test
Ontera Awarded Contract for Zika Genotyping Test
Two NewMembers Join Global Diagnostics Network
BARDA Funding Health Security Solutions

5. Profiles of Key Players

5.1 Key Players-Therapeutics

Applied DNA Sciences, Inc
Codagenix
GeoVax Labs, Inc
Takis Biotech
Evvivax
Zydus Cadila
MIGAL Galilee Research Institute
Generex Biotechnology Corporation
Moderna Therapeutics
Novavax
Bravovax
Ascletis Pharma
Janssen Pharmaceuticals
Altimmune
Greffex Inc
CanSino Biologics, Inc
ExpreS2ion Biotechnologies ApS
Clover Biopharmaceuticals
Vaxil Bio Ltd
iBio Pharma Inc
Tonix Pharmaceuticals
Curevac
ImmunoPrecise
X4 Pharmaceuticals
Inovio Pharmaceuticals
Innovation Pharmaceuticals
CytoDyn
BIOXYTRAN
BioCryst Pharmaceuticals
Vir Biotechnology
NanoViricides
TAKISAWA Technology Co., Ltd
Westway Health
NabrivaTherapeutics
NemesisBioscience
Armata Pharmaceuticals, Inc
Lumavita
Priaxon
Union Therapeutics
Enanta Pharmaceuticals, Inc
Demuris
Prommune
Vaxart
Alexion Pharmaceuticals
SelectXPharmaceuticals, Inc
TaiGen Biotechnology Co., Ltd
Abbvie
KYORIN Pharmaceutical Co., Ltd
Forge Therapeutics
Alopexx Vaccine LLC
Integrated Biotherapeutics
Hennepin Life Sciences
Contrafect Corporation
Basilea Pharmaceutica Ltd
AiCuris
Redx Pharma Plc/ Redx Anti Infectives Ltd
Centauri Therapeutics Ltd
Combioxin SA
Mutabilis SAS
Vaxdyn
Vibiosphen
Bioaster
Vivexia
KBP Biosciences
Merck
Symphogen
Johnson & Johnson (Janssen)
Pfizer
Allergan
GlaxoSmithKline
Novartis
Gilead Sciences
AstraZeneca
Sanofi
Shionogi Inc
Cipla
DSM Sinochem Pharmaceuticals
Wockhardt Ltd
VenatoRx Pharmaceuticals

5.2 Key Players-Diagnostics

Abbott Diagnostics
Accelerate Diagnostics
Ador Diagnostics
Akkoni Biosystems
Alveo Technologies
Applied BioCode
Aus Diagnostics
BD Diagnostics
Biocartis
BioFire Diagnostics
bioMerieux
Bio-Rad Laboratories
Bosch Healthcare Solutions GmbH
Cepheid
Co-Diagnostics
Cue Health
Curetis
Diagenode Diagnostics
Diascopic
Diasorin
Expedeon
Fusion Genomics
GenePOC Diagnostics
GenMark Dx
Hologic
Immunexpress
Inflammatix
Invetech
Janssen Diagnostics
Karius
Lexigene
Luminex
Mbio Diagnostics
Meridian Bioscience
Mesa Biotech
Mobidiag
Nanomix
Oxford Nanopore
Panagene
Primerdesign
Prominex
Qiagen (Statdx)
Quantumdx
Quidel
Roche Molecular Diagnostics
Saw Diagnostics
Seegene
Sensovation
Siemens Healthineers (Fast Track Diagnostics)
SkylineDx
Sona Nanotech
T2 Biosystems
Thermo Fisher
Veradus Labs
Veramarx

6. COVID-19 Economic Impact on Gross Domestic Product
6.1 Economic Impact Overview by Country
6.2 Tourism Global Market by Segment-Overview
6.3 Medical Global Market by Segment and Scenario-Overview

7. Tourism Global Markets-By Segment and Scenario
7.1 Hotels
7.2 Ground
7.3 Air Travel
7.4 Cruise Market
7.5 Other Tourism

8. Medical Global Markets-By Segment and Scenario
8.1 Therapeutic
8.2 Diagnostics
8.3 PPE

For more information about this report visit https://www.researchandmarkets.com/r/jytj4o

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets